Neurotoxic Medications

…the treatment with their physician to see if other precautions or preventative treatments are needed. I am treating a 20-year-old patient with leukemia. After his fourth dose of vincristine, he…

Medications for CMT Peripheral Neuropathy

…bound with limited leg movement may be at higher risk and should discuss the treatment with their physician to see if other precautions or preventative treatments are needed. I am…

A New Treatment for CMT1A

DTx Pharma is directly targeting the genetic cause for CMT1A in its upcoming clinical development program. DTx Pharma is developing a treatment for CMT1A that directly targets the cause of…

Data Shows Benefit with PXT3003 in Patients with CMT1A

treatments. Pharnext has two lead products in clinical development. PXT3003 completed an international Phase III trial with encouraging topline results for the treatment of Charcot-Marie-Tooth disease type 1A (‘CMT1A’) and…

CMT1A Ionis Press Release

New Research Shows Promise for CMT Progressive Neuromuscular Disease Potential treatment offers hope for over 2.8 million affected worldwide Glenolden PA, December 4, 2017—A new paper published December 4th on…